Side Effect Patterns in a Crossover Trial of Statin, Placebo, and No Treatment (SAMSON)

Many patients abandon statins because of muscle aches and other symptoms. This ingenious crossover trial (SAMSON) asked how much of that suffering is actually caused by the drug — and the answer reframed the whole problem.

Patients with a history of statin intolerance took, in randomized monthly rotations, the statin, an identical placebo, or no pill at all, rating their daily symptoms. The result: symptom intensity was nearly identical during statin months and placebo months, and both were much higher than during no-pill months. In other words, about 90 percent of the symptom burden was a nocebo effect — produced by the act of taking a pill, not by the statin itself. Most participants were able to restart statins afterward.

This is a profound and practical finding. It means most “statin side effects” are real symptoms with a non-pharmacological cause, and that the great majority of patients labeled intolerant can in fact take the drug that protects them.

We rate the evidence strong. Though small, its rigorous blinded crossover design makes it a landmark in understanding statin intolerance — directly useful for keeping patients on life-saving therapy.